Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics?
Background: Helicobacter pylori (HP) infection plays a significant role in the development of gastrointestinal complications and has a significant role in systemic inflammation. It has some extragastrointestinal manifestations like endocrine diseases. In this study, we aimed to compare the prevalence of HP infection in diabetic and nondiabetic individuals. Materials and Methods: In this cross-sectional study, 218 nondiabetic and 211 diabetic patients referring to Shahid Beheshti Hospital of Qom between March 2013 and 2014 were studied. The patients were divided into two HP + and HP− groups based on serological immunoglobulin G antibody against HP and the association between diabetes, and HP infection was evaluated. Data were analyzed using independent t-tests, Chi-square, Fisher′s exact and Mann-Whitney tests. Results: The prevalence of HP seropositive was 65.9% versus 50.5% in diabetic and nondiabetics, respectively, and the difference was statistically significant (P = 0.001). Conclusions: This study showed a higher prevalence of HP infection in diabetic patients..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Indian Journal of Endocrinology and Metabolism - 19(2015), 3, Seite 364-368 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jamshid Vafaeimanesh [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Diabetic |
|---|
| doi: |
10.4103/2230-8210.152773 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ035894873 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ035894873 | ||
| 003 | DE-627 | ||
| 005 | 20230503095530.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/2230-8210.152773 |2 doi | |
| 035 | |a (DE-627)DOAJ035894873 | ||
| 035 | |a (DE-599)DOAJ35bac54ad42a4f5896959d74dbbea507 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC648-665 | |
| 050 | 0 | |a RC799-869 | |
| 100 | 0 | |a Jamshid Vafaeimanesh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics? |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background: Helicobacter pylori (HP) infection plays a significant role in the development of gastrointestinal complications and has a significant role in systemic inflammation. It has some extragastrointestinal manifestations like endocrine diseases. In this study, we aimed to compare the prevalence of HP infection in diabetic and nondiabetic individuals. Materials and Methods: In this cross-sectional study, 218 nondiabetic and 211 diabetic patients referring to Shahid Beheshti Hospital of Qom between March 2013 and 2014 were studied. The patients were divided into two HP + and HP− groups based on serological immunoglobulin G antibody against HP and the association between diabetes, and HP infection was evaluated. Data were analyzed using independent t-tests, Chi-square, Fisher′s exact and Mann-Whitney tests. Results: The prevalence of HP seropositive was 65.9% versus 50.5% in diabetic and nondiabetics, respectively, and the difference was statistically significant (P = 0.001). Conclusions: This study showed a higher prevalence of HP infection in diabetic patients. | ||
| 650 | 4 | |a Diabetic | |
| 650 | 4 | |a Helicobacter pylori | |
| 650 | 4 | |a nondiabetic | |
| 650 | 4 | |a prevalence | |
| 653 | 0 | |a Diseases of the endocrine glands. Clinical endocrinology | |
| 653 | 0 | |a Diseases of the digestive system. Gastroenterology | |
| 700 | 0 | |a Mahmoud Parham |e verfasserin |4 aut | |
| 700 | 0 | |a Mohammad Bagherzadeh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Indian Journal of Endocrinology and Metabolism |d Wolters Kluwer Medknow Publications, 2011 |g 19(2015), 3, Seite 364-368 |w (DE-627)DOAJ000067717 |x 22309500 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2015 |g number:3 |g pages:364-368 |
| 856 | 4 | 0 | |u https://doi.org/10.4103/2230-8210.152773 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/35bac54ad42a4f5896959d74dbbea507 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.ijem.in/article.asp?issn=2230-8210;year=2015;volume=19;issue=3;spage=364;epage=368;aulast=Vafaeimanesh |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2230-8210 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2230-9500 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2015 |e 3 |h 364-368 | ||